Taken together, these results suggest that this de novo activation of the coregulated chromatin region comprising PRDM5 and NDNF drives the coordinated overexpression of both genes, but only PRDM5 seems to be related to MM pathogenesis. This evidence concerns the gene PRDM5 and Miyoshi myopathy.